GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets. The company is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) market cap is $226.41M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) 52 week high is $11.84 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) 52 week low is $8.57 as of November 21, 2026.
GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) stock price today is $8.75.
GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) stock price yesterday was $8.57.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) P/B ratio is 1.1861.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. GreenLight Biosciences Inc - Units (1 Ord Class A & 1/2 War) 50-day moving average is $10.34.